Skip to main content
. 2017 Sep 20;8(46):81195–81203. doi: 10.18632/oncotarget.21092

Table 4. Clinical characteristics of young patients with AMI.

Variables Groups P-value Groups P-value
Non-events in hospital (n = 2065) Events in hospital (n = 123) Non-events out of hospital (n = 2098) Events out of hospital (n = 90)
Deographic and clinical
 Age (yrs) 39.9 ± 4.6 39.4 ± 4.9 NS 39.8 ± 4.7 39.6 ± 4.3 NS
 Heart rate (beats/min) 73.4 ± 12.7 79.4 ± 17.7 0.000 73.7 ± 13.0 74.5 ± 14.0 NS
 SBP (mm Hg) 120.8 ± 16.3 119.1 ± 19.3 NS 120.7 ± 16.5 120.5 ± 16.2 NS
 DBP (mm Hg) 75.9 ± 11.9 75.1 ± 14.3 NS 75.9 ± 12.1 76.7 ± 12.5 NS
 BMI (kg/m2) 28.1 ± 3.2 28.3 ± 3.1 NS 28.1 ± 3.1 28.2 ± 3.6 NS
 Male (%) 1964(95.1) 113(91.8) NS 1991(94.8) 86(95.5) NS
 Alcohol use (%) 615(29.7) 31(25.2) NS 628(29.9) 18(20.0) 0.043
 Smoke (%) 1427(69.1) 79(64.2) NS 1449(69.0) 57(63.3) NS
 Hypertension (%) 816(39.5) 59(47.9) NS 840(40.0) 35(38.8) NS
 Diabetes mellitus (%) 387(18.7) 31(25.2) NS 401(19.1) 17(18.8) NS
 Hyperlipidemia (%) 667(32.3) 39(31.7) NS 653(31.1) 30(33.3) NS
 Family historyof CAD (%) 244(11.8) 11(8.9) NS 243(11.5) 12(13.3) NS
 Prior MI (%) 86(4.1) 7(5.6) NS 91(4.3) 2(2) NS
Biochemical
 TC (mmol/L) 4.73 ± 1.22 4.58 ± 1.07 NS 4.73 ± 1.22 4.61 ± 1.01 NS
 TG (mmol/L) 2.75 ± 7.10 2.01 ± 1.29 NS 2.75 ± 7.09 2.00 ± 1.31 NS
 LDL-c (mmol/L) 3.15 ± 5.81 2.80 ± 0.88 NS 3.15 ± 5.81 2.83 ± 0.84 NS
 HDL-c (mmol/L) 0.96 ± 0.22 0.98 ± 0.26 NS 0.96 ± 0.22 0.99 ± 0.26 NS
 Scr (μmol/L) 80.28 ± 38.51 81.15 ± 24.46 NS 80.35 ± 38.51 79.85 ± 23.54 NS
 BUN (mmol/L) 7.35 ± 4.82 6.56 ± 4.21 NS 7.34 ± 4.82 6.85 ± 4.34 NS
 ALT (U/L) 46.25 ± 35.83 56.76 ± 41.31 NS 46.35 ± 35.88 55.58 ± 41.31 NS
 γ-GT (U/L) 51.88 ± 48.94 65.52 ± 83.02 NS 52.44 ± 50.08 66.40 ± 89.18 NS
 CK (U/L) 842.38 ± 1286.09 1332.34 ± 1708.09 0.015 848.52 ± 1293.33 1229.67 ± 1640.81 0.049
 CK-MB (ng/ml) 79.84 ± 181.77 106.74 ± 148.63 NS 80.29 ± 181.82 98.99 ± 147.31 NS
 cTnT (ng/ml) 2.17 ± 2.04 3.25 ± 4.83 0.048 2.20 ± 2.21 2.69 ± 3.31 NS
 BNP (pg/ml) 481.87 ± 2659.16 1140.97 ± 3404.97 NS 483.85 ± 2648.81 1199.77 ± 3624.89 NS
 Glucose (mmol/L) 6.98 ± 2.87 8.08 ± 4.90 0.048 6.99 ± 2.89 7.94 ± 4.86 NS
 Glycosylatedhemoglobin (%) 6.55 ± 1.87 6.10 ± 1.32 NS 6.48 ± 1.82 6.32 ± 1.55 NS
Hematologic
 Hemoglobin (g/L) 147.23 ± 15.54 143.74 ± 16.65 NS 147.22 ± 15.57 143.65 ± 16.09 NS
 Red cell count (10*12/L) 5.83 ± 2.04 5.16 ± 1.89 0.003 5.83 ± 2.04 5.21 ± 1.92 0.008
 White cell count (10*9/L) 10.42 ± 3.55 10.44 ± 4.27 NS 10.41 ± 3.56 10.53 ± 4.25 NS
 PLT (10*9/L) 239.78 ± 61.07 210.60 ± 46.11 0.043 238.03 ± 60.65 215.60 ± 50.72 NS
 RDW 12.94 ± 0.71 13.25 ± 0.95 NS 12.94 ± 0.70 13.38 ± 1.03 0.034
Echocardiography
 LVDd (mm) 50.13 ± 5.06 50.15 ± 5.62 NS 50.14 ± 5.13 49.90 ± 4.16 NS
 IVST (mm) 10.20 ± 1.58 10.40 ± 1.47 NS 10.22 ± 1.58 10.20 ± 1.29 NS
 EF (%) 57.70 ± 8.52 54.53 ± 9.07 0.000 57.45 ± 8.54 58.62 ± 9.48 NS
Diagnosis 0.030 NS
 NSTEMI 1648(79.8) 108(87.8) 1685(80.3) 71(78.8)
 STEMI 417(20.1) 15(12.1) 413(19.6) 19(21.1)

SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; BMI: Body Mass Index; NSTEMI: non-ST-segment myocardial infarction; STEMI: ST-segment elevation myocardial infarction; TC: total cholesterol; TG: triglyeride; LDL: low density lipoprotein cholesterol; HDL: high density lipoprotein cholesterol; Cr: creatinine; BUN: blood urea nitrogen; ALT: alanine aminotransferase; AST: Aspartate transaminase; CK: creatine kinase; CKMB: creatine kinase MB isoenzyme; cTnT: Cardiac Troponin T; NT-proBNP: N-terminal pro-B-type natriuretic peptide; HbA1c: hemoglobin A1c; PLT: platelet; RDW: red blood cell distribution width; LVDd: left ventricular end-diastolic dimension; IVST: interventricular septal thickness; EF: ejection fraction; NS: not significant.